Prenetics Global Limited (PRE)
NASDAQ: PRE · Real-Time Price · USD
13.99
+0.06 (0.43%)
At close: Dec 5, 2025, 4:00 PM EST
14.27
+0.28 (2.00%)
After-hours: Dec 5, 2025, 5:38 PM EST
Prenetics Global Revenue
Prenetics Global had revenue of $23.56M in the quarter ending September 30, 2025, with 202.84% growth. This brings the company's revenue in the last twelve months to $77.08M, up 201.54% year-over-year. In the year 2024, Prenetics Global had annual revenue of $30.62M with 40.83% growth.
Revenue (ttm)
$77.08M
Revenue Growth
+201.54%
P/S Ratio
2.40
Revenue / Employee
$270,453
Employees
285
Market Cap
235.43M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 30.62M | 8.88M | 40.83% |
| Dec 31, 2023 | 21.74M | 8.58M | 65.17% |
| Dec 31, 2022 | 13.16M | 631.26K | 5.04% |
| Dec 31, 2021 | 12.53M | -52.65M | -80.77% |
| Dec 31, 2020 | 65.18M | 55.95M | 605.93% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
PRE News
- 10 days ago - Prenetics Announces Upcoming Conference Participation - GlobeNewsWire
- 11 days ago - Prenetics Executives Announce Open Market Share Purchases Totaling Approx. $1.45 Million - GlobeNewsWire
- 21 days ago - Cantor Fitzgerald Reiterates Overweight Rating on Prenetics with Price Target of $31 Following Strong IM8 Growth - GlobeNewsWire
- 25 days ago - Prenetics Reports Record Third Quarter 2025 Results; IM8 on Track for $120M ARR¹ by December 2025, Fastest Supplement Brand Growth in Industry History - GlobeNewsWire
- 4 weeks ago - Prenetics' IM8 Achieves Record $9 Million in Revenue for October, Surpasses $108 Million in Annualized Recurring Revenue 11 Months After Launch - GlobeNewsWire
- 5 weeks ago - Prenetics Bolsters Bitcoin Treasury with Strategic Acquisition of 100 Bitcoin, IM8 Reaches $100M ARR - GlobeNewsWire
- 5 weeks ago - Prenetics CEO Danny Yeung Publishes "The Dual-Engine Revolution" Manifesto: A Blueprint for the Future of Health + Wealth - GlobeNewsWire
- 5 weeks ago - Prenetics Announces Closing of Approx. $44.0 Million Equity Offering to Fuel IM8's Global Expansion and Bitcoin Treasury Strategy - GlobeNewsWire